Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The outstanding antitumor capacity of CD4+ T helper lymphocytes

24 Sept 2020

Abstract excerpt

Over the past decades, tumor-resident immune cells have been extensively studied to dissect their biological functions and clinical roles. Tumor-infiltrating CD8+ T cells, because of their cytotoxic and killing ability, have been under the spotlight for a long time, whereas CD4+ T cells are considered just a supporting actor in the field of cancer immunotherapy. Until recently, accumulating evidence has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32980465
DOI: 10.1016/j.bbcan.2020.188439

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The outstanding antitumor capacity of CD4+ T helper lymphocytesPMID 32980465Read ↗

Expanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and TherapySemantic proximity Read ↗

Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolboxSemantic proximity Read ↗

T lymphocyte subsets in cancer immunity: Friends or foesSemantic proximity Read ↗

CD4 and CD8 T lymphocyte interplay in controlling tumor growthSemantic proximity Read ↗

Tumor antigen‐specific CD4 + T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategiesSemantic proximity Read ↗

Consensus nomenclature for CD8+T cell phenotypes in cancerSemantic proximity Read ↗

Cancer immunosurveillance by CD8 T cellsSemantic proximity Read ↗

Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review)Semantic proximity Read ↗

The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy.Semantic proximity Read ↗

The Era of Cytotoxic CD4 T CellsSemantic proximity Read ↗

Role of CD4 + Cytotoxic T Lymphocytes in the Control of Viral Diseases and CancerSemantic proximity Read ↗

CD4+ Cytotoxic T cells - Phenotype, Function and Transcriptional Networks Controlling Their Differentiation Pathways.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.